We prove the efficacy of the HDAC10 inhibitor PZ48 in a Danio rerio larvae model and speculate that HDAC10 inhibitors might be prospectively used to treat aggressive lymphocytic leukemia. Here, HDAC10 is linked to lymphoid leukemia.